Theriva Biologics, Inc.
TOVXTheriva Biologics, Inc. (TOVX) is a biotechnology company focused on the development of targeted therapies for cancer and other diseases. The company specializes in the design and engineering of oncolytic viruses and other biologic treatments to improve safety and efficacy in cancer therapy. Based in the United States, Theriva aims to advance innovative solutions through its proprietary platforms and collaborations.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 10, 2008 | $0.05 | 2007-12-27 | 2007-12-31 |
Dividends Summary
- Theriva Biologics, Inc. has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 6542 days ago, on January 10, 2008
- The highest dividend payed out to investors during this period was $0.05 per share
- The average dividend paid during this period was $0.05 per share.
Company News
Theriva Biologics reported unusual trading activity in its stock on October 24, 2025, and stated there are no material undisclosed developments causing the market action. The company is developing cancer therapeutics and has recently presented expanded data from its VIRAGE trial at ESMO 2025.
US stock futures are trading higher ahead of a shortened trading session on Christmas Eve. Analysts expect a 'Santa Rally' during this period, which has historically seen positive returns. However, they also caution about potential market corrections in 2025 due to stretched valuations.
